SKK
ANTH

Shepherd Kaplan Krochuk’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,688
Closed -$73K – 629
2014
Q2 		$73K Sell
2,688
-562
-17% -$13.9K 0.01% 523
2014
Q1 		$87K Buy
+3,250
New +$82.5K 0.01% 538

Other funds holding ANTH

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
GCM
Gruss Capital Management New York $715M AUM 9.91% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

Shepherd Kaplan Krochuk's ANTH Position: Q3 2014 in Review

Shepherd Kaplan Krochuk sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q3 2014, closing a stake of 2,688 shares — an estimated $73K sold.

Shepherd Kaplan Krochuk first reported a position in ANTH in Q1 2014 and held it in 2 quarters. The position peaked at $87K in Q1 2014. 35 funds tracked by Wall St. Rank hold ANTH as of Q3 2014.

  • Shepherd Kaplan Krochuk reported no remaining Anthera Pharmaceuticals, Inc. position as of Q3 2014 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 2,688 Anthera Pharmaceuticals, Inc. shares in Q3 2014, an estimated $73K.
  • Shepherd Kaplan Krochuk first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2014 and held it in 2 quarters.
  • Shepherd Kaplan Krochuk's Anthera Pharmaceuticals, Inc. position peaked at $87K in Q1 2014.
  • 35 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q3 2014.

Based on Shepherd Kaplan Krochuk's 13F filing for Q3 2014, filed 13 Nov 2014.